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the control group (P>0.05); there were signiﬁcant changes in NT-pro
BNP (P<0.05).
4. There were signiﬁcant changes in PaO2 in both groups after the
experiment (P<0.05), there were no signiﬁcant changes in NT-pro
BNP, PH, PaCO2, HCO3-, SaO2 group (P> 0.05).
5. There were no signiﬁcant changes in Naþ, Kþ, Cl-, Ca2þ con-
centration and creatinine.
CONCLUSIONS This study shows that inhaled furosemide for heart
failure patients improve hypoxemia and dyspnea have a role in the
degree of reduction. To reduce cardiac wall tension, decreased plasma
levels of NT-pro BNP is not helpful. Study of inhaled furosemide
serious adverse event occurred, it has a good safety.
GW26-e5448
A simple score model to predict 30-day in-hospital mortality in patients
with acute decompensate heart failure at admission only by patients’ age
and comorbidities
Yamin Cao, Yanming Chen, Xingli Wu, Yusheng Zhao
Chinese PLA General Hospital
OBJECTIVES More and more patients with acute decompensate heart
failure(ACHF) appear in hospitals. How to estimate in-hospital mor-
tality and stratify these patients become very important, but simple
and easy to handle approaches are few. The article tried to develop a
practical score model.
METHODS A total of 6,949 patients were identiﬁed from the hospital
database. The patient whose hospital stay was over less than 30-day
were included. The basic characters, all kinds of co-morbidities and all
cause deaths in hospital within 30-day were recorded from the pa-
tients’ medical ﬁle.
All co morbidities that co-existed in patients were collected. Percent-
ages were reported to describe categorical variables, mean  SD to
describe the continuous variables. The variables that associated with 30-
day in-hospital death were pick out by univariate analysis from the
candidate variables, and were included in a multiple logistic regression
model as predicting covariates. Age and nine co morbidities were corre-
lated with the 30-day in-hospital death and became valuable predictors.
Score rulers for the 30-day in-hospital mortality came from logistic
regression by a regression coefﬁcient-based scoring method. A patient 30-
day in-hospital death risk could be estimated by his general score which
could be gotten by summing the score of each predictor the patient had.
Categorical variables were compared using the c2 test, and the contin-
uous variables were compared among the 5 groups using 1-way analysis
of variance followed by the post hoc Bonferroni multiple comparisons
test. The discrimination of this model was valued by the area under
receiver operator characteristic curve (AUC). All statistical tests were
performed using SPSS 16.0 for Windows (SPSS Inc., Chicago, Inc.).
RESULTS 6,949 patients were included. There were totally 19
comorbidities were collected. The 30-day in-hospital mortality of
patients with ADHF was 5.4%. There are nine comorbidities: the
COPD, stroke, renal failure, cirrhosis of liver, myocardial infarction
(MI), pneumonia, gastrointestinal bleeding and multiple organ
dysfunction syndromes (MODS) and age older than 65 years are the
independent risk factors of the 30-day in hospital death. According to
his total score, a patient could be stratiﬁed into very low, low, mod-
erate and high death risk grade.
The power of the score mode was assessed by the area under the
receiver operating characteristic curve (AUC), the AUC of the score is
0.778, 0.122 larger than using comorbidities directly.
CONCLUSIONS By the model the estimation of 30-day in-hospital
mortality in patients with ADHF could be gotten only by patients’ age
and comorbidities at admission at once.
GW26-e0183
Study on change in levels of HMGB1, TNF-a, Chemerin in Patients with
Congestive Heart Failure And Its Relationship with ventricular remodeling
Aiqi Xi, Baoxia Liao
the People’s Hospital of Qinghai Province, Xining, Qinghai
OBJECTIVES To study the change of serum high mobility group box 1
protein (HMGB1), tumor necrosis factor-a (TNF-a), Chemerin and its
relationship with ventricular remodeling in patients with congestive
heart failure(CHF).
METHODS A total of 74 consecutive patients with CHF (36 cases of
cardiac function levels II, 38 cases of levels III) and 27 healthy subjects
with matched age and sex were enrolled. The levels of HMGB1,TNF-aand Chemerin were measured by ELISE. Left ventricular ejec-
tion fraction(LVEF) from echocardiography and left ventricular mass
index (LVMI), mean wall stress (MWS) was calculated.
RESULTS LVEF in patients with CHF were lower than that in healthy
subjects (40.2311.56)% vs (68.737.05)%, the levels of HMGB1,
TNF-a, Chemerin and LVMI, MWS were on the contrary [(27.386.81)
pg/ml vs (9.521.82) pg/ml, (86.459.13) ng/L vs (25.265.23) ng/L,
(267.53 31.05) ng/mL vs ( 123.8724.74) ng/mL, (184.412.1 ) vs
(76.98.7)g/m2 and (439.627.9) vs (223.519.7) dynes103/cm2, all
p<0.01 respectively]. With the increase of NYHA and development of
disease, the levels of HMGB1, TNF-a, Chemerin and LVMI, MWS
signiﬁcantly increased; and the levels of HMGB1, TNF-a and Chemerin
were positive correlation with LVMI and MWS (P<0.01). but a negative
correlation with LVEF (P<0.01).
CONCLUSIONS Change of the levels of serum HMGB1, TNF-a, Chemerin
and LVMI, MWS in the patients with CHF can reﬂect impairment of the
cardiac function and the degree of ventricular remodeling. Increasing in
the levels of serum HMGB1, TNF-a, Chemerin and MWS is earlier than the
pathologic structural change of left ventricular remodeling.It is suggested
that change of the levels of HMGB1, TNF-a, Chemerin and LVMI, MWS
play a role in the pathophysiological and pathogenetic mechanism of
chronic heart failure, they may interact and inﬂuence each other and lead
to ventricular remodeling.
GW26-e2326
The effect of serum N-terminal pro-brain natriuretic peptide(NT-proBNP)
and QTc interval dispersion in the diagnosis of CHF and evaluation of heart
function
Ruihua Wang, Yanfen Li, Yuhong Huang, Lanjun Sun
The Second Afﬁliated Hospital of Tianjin University of Traditional
Chinese Medicine
OBJECTIVES By observing the relationship between serum N-terminal
pro-brain natriuretic peptide (NT-proBNP) concentration, QTc interval
dispersion (QTcd) and the NYHA heart function classiﬁcation, left ven-
tricular ejection fraction (LVEF), we study the effection of NT-proBNP and
QTcd in the diagnosis of CHF and evaluation of heart function.
METHODS We select 84 hospitalized patients with CHF disease and
60 healthy controls from 2014 March to December in our hospital.The
serum NT-proBNP concentration was measured by immune chem-
iluminescence method.QTc interval was detected by Mortara 12 lead
ECG ELI250, LVEF was determined by America HP5500 type color
echocardiography, heart funtion in patients with CHF was classiﬁed
according to the NYHA.
RESULTS The mean serum NT-proBNP concentration in patients with
CHF (323.3816.41) pg/ml and QTc interval dispersion (42.84 4.16) ms
was signiﬁcantly higher than that in healthy controls (44.876.20) pg/ml,
23.35 3.00) ms, there were statistically differences P <0.01. There was a
positive correlation between serum NT-proBNP concentration and QTc
interval dispersion (r¼0.817, P<0.01). There was a signiﬁcant positive
correlation between NYHA classiﬁcation and NT-pro BNP concentration,
QTc interval dispersion (r¼0.834, P <0.01), (r¼0.830, P<0.01). There was
a signiﬁcant negative correlation between LVEF and NT-proBNP, QTc
interval dispersion (r ¼-0.770, P <0.01), r ¼-0.810, P <0.01). The analysis
of effects of NT-pro BNP, QTcd in the diagnosis of heart failure by
employing the receiver operating characteristic(ROC) curve led to the
result that the area under the curve AUC were 0.806 and 0.712,95%
respectively and conﬁdence interval were 0.737-0.875 and 0.603-0.822,
respectively with the existence of statistical difference. The diagnostic
cutoff value respectively was 128.45pg/ml,42.3ms; the Youden index
which was the highest, respectivelywas 0.807,0.706.
CONCLUSIONS NT-pro BNP and QTc interval dispersion can be
objective and accurate assessment of heart function in patients with
chronic congestive heart failureNT-pro BNP and QTc interval disper-
sion have ideal sensitivity and speciﬁcity in diagnosis of heart failure
NYHA classiﬁcation and left ventricular systolic dysfunction and can
be used as a laboratory marker of clinical diagnosis and heart failure
degree evaluation.
GW26-e2439
Based on clinical studies of plasma NT-proBNP for the diagnosis of
diastolic heart failure optimal cutoff value observed
Qixia Heng
Zhongmou County People’s Hospital
OBJECTIVES To investigate the relationship between high blood
pressure in patients with plasma NT-proBNP and diastolic heart
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relationship between the severity of diastolic dysfunction, and get
plasma NT-proBNP in the diagnosis of diastolic heart failure most
good community values.
METHODS The study is outpatient or inpatient treatment of non-
systolic heart failure in patients with hypertension 61 cases were
divided into three groups: no clinical signs and symptoms of heart
failure, echocardiography without diastolic dysfunction group I;
clinical None signs and symptoms of heart failure, echocardiographic
diastolic dysfunction group II; clinical signs and symptoms of heart
failure, echocardiographic diastolic dysfunction group III. In 20
healthy control group. All patients enrolled in clinical data are
collected to determine the presence or absence of heart failure, and
cardiac function NYHA classiﬁcation. 24 hours of admission or treat-
ment echocardiography expert to determine whether the diastolic
dysfunction and diastolic function of the extent of becoming divided
into four weight: I level (normal diastolic function), grade II (impaired
relaxation), III grade (pseudo- normalization ﬁlling), grade IV
(restrictive ﬁlling). Admission or treatment plasma NT-proBNP con-
centrations within 24 hours. Comparison between different experi-
mental groups, between different classiﬁcation of diastolic function,
plasma NT-proBNP levels between different NYHA class; evaluate the
relationship between echocardiographic indices of diastolic function
and plasma NT-proBNP for; were constructed NT-proBNP diagnostic
diastolic dysfunction and diastolic ROC curve of heart failure, and
were the best diagnostic cutoff value.
RESULTS The area under the ROC curve of plasma NT-proBNP diag-
nosis of diastolic heart failure (AUC) was 0.886 (95% CI 0.818-0.954,
P ¼ 0.000). Plasma NT-proBNP when 112.45pg/ml, diastolic heart
failure diagnostic sensitivity 94.0%, speciﬁcity 81.8%, positive pre-
dictive value of 72.7%, negative predictive value of 94.6%.
CONCLUSIONS The plasma NT-proBNP for diagnosis of diastolic heart
failure is valuable.
GW26-e3591
Predicting Value of Biomarkers for Short-Term Outcomes in Acute Heart
Failure
Rongrong Gao, Xinli Li
The First Afﬁliated Hospital of Nanjing Medical University
OBJECTIVES B-type natriuretic peptide (BNP) and N-terminal pro-B-
type natriuretic peptide (NT-proBNP) are increasingly being used to
guide the management of acute heart failure (AHF) patients. This
study aims to explore some new biomarkers providing predicting
values for short term prognosis in patients with AHF.
METHODS A total of 206 patients with AHF were enrolled and fol-
lowed for 3 months. Baseline level of complete blood count, complete
biochemistry, D-dimer and NT-proBNP were measured at admission
or the following morning. Primary endpoints of the study were car-
diovascular (CV) events, deﬁned as cardiac death and/or readmission
for AHF.
RESULTS During the 90-day follow-up period, 15 patients died and 10
patients were re-hospitalized due to worsening of heart failure
(12.14%). Red cell distribution width (RDW), D-dimer and NT-proBNP
were signiﬁcantly higher in the patients who had a CV events at the
90-day (p < 0.001). The area under receiver operating characteristic
(ROC) curve (AUC) of NT-proBNP, D-dimer and RDW for predicting CV
events by 90- day was 0.806, 0.887 and 0.754. Kaplan-Meier survival
curve for 90-day CV events showed that patients with a D-dimer level
> 1.1mg/dL and NT-proBNP > 2262.0pg/mL were at high risk (p <
0.001) for short-term outcomes of AHF.
CONCLUSIONS D-dimer could be as a new biomarker combined with
NT-proBNP for predicting early prognostic value to cardiovascular
events of AHF.
GW26-e4381
Resveratrol protects the heart from sepsis without systemically
anti-inﬂammatory effect
Tao Bai,1,2 Fan Wang,3 Lu Cai,2 Yang Zheng1
1Cardiovascular Center, The First Hospital of Jilin University,
Changchun, China; 2KCHRI of Department of Pediatrics, the University
of Louisville, KY, USA; 3Department of Infective Disease, People’s
Hospital of Jilin Province, Changchun, China
OBJECTIVES Resveratrol can protect the heart from sepsis, but the
detailed mechanism remains unknown; therefore, we try to explore
the mechanism.METHODS FVB and C57BL/6J male mice (age: 8 weeks; body weight:
20-25g) were subjected to lipopolysaccharide (LPS) injection at 6 mg/
kg to set up a sepsis model. One study included 5 groups: Group 1
(control mice); Group 2 (intraperitoneal injection with LPS); Group 3
(treated with resveratrol only for 3 days); Group 4 (treated with
resveratrol for 3 days before LPS); Group 5 (treated with LPS and
resveratrol at same time). These mice were sacriﬁced at 48 h after LPS
treatment. The dose of resveratrol was 20 mg/kg/d. Serial echocar-
diograms were performed to assess cardiac function.
RESULTS In both strains of mice, LPS injection could signiﬁcantly
decrease the left ventricular EF% from 6 to 48 hour. For resveratrol
prevention study, we found that tumor necrosis factor alpha (TNF-a)
levels in plasma and heart tissue were signiﬁcantly increased at 6 h
after LPS injection in groups 2, 4, and 5, compared to the groups 1 and
3. Among the groups 2, 4 and 5 there was no signiﬁcant difference.
CD45 is a pan-leukocyte marker, heart wax section immunohisto-
chemistry staining for CD 45 shows no difference in all groups. Using
immune blot and ELISA to assess the ratio of cleaved caspase 3 to
caspase 3 and plasma level of troponin I, markers for cardiac cell
apoptosis and injury, respectively, showed no difference in all groups,
which indicates that cardiac dysfunction in sepsis is not due to cardiac
cell loss. Time-course comparison between FVB and C57BL/6J mice,
we found that C57BL/6J mice was more susceptible to FVB mice since
the former showed a signiﬁcant decrease (more than 50%) in EF%
while FVB mice showed about 40% decrease in EF%. However, car-
diac dysfunction of C57BL/6J mice showed a faster recovery from 6 to
24 hour compared to FVB that recovered from 6 to 48 hours.
CONCLUSIONS Resveratrol protection of the heart from sepsis is not
due to its prevention of LPS-induced inﬂammation. Since resveratrol
is a multiple bioactive natural compound, we should focus other
mechanisms to explore how resveratrol protect heart from sepsis in
the future studies.
GW26-e5471
The Correlation between Cardiac function in patients with different
classiﬁcation levels of serum NT-proBNP and cardiac function
Zhiqing Fan,1 Pinghui Sun2
1Department of Cardiology, Daqing Oil Field General Hospital, China;
2Jilin University college of public health statistics teaching and
research, Changchun, China
OBJECTIVES To observe correlation between the standard of N-ter-
minal pro-B-type natriuretic peptide (NT-proBNP) and cardiac func-
tion in different NYHA classiﬁcation, LVEF and LVED.
METHODS For the 83 patients of heart failure in hospital, to assay
their NT-proBNP of blood serum by enzyme-linked immunosorbent
assay (ELISA) and determine their LVEF and LVED by UCG. To analyse
the correlation of patients’ NT-proBNP, the different cardiac func-
tional grading and the indexes above-mentioned.
RESULTS (1) Different NYHA cardiac function classiﬁcation levels of
serum NT-proBNP levels was signiﬁcantly. Its level is positively
correlated with cardiac function. (2) NT-proBNP is negatively corre-
lated with LVEF and positively correlated with the LVED.
CONCLUSIONS NT-proBNP measurement is one of the methods of
effective assistance in clinical diagnosis of heart failure, on the whole
reﬂect the severity of heart failure.
GW26-e0191
Altitude difference of HMGB1, Fetuin-A in the patients with congestive
heart failure and effects on ventricular remodeling
Aiqi Xi, Guofeng Li
the People’s Hospital of Oinghai Province
OBJECTIVES Inﬂammation and dystrophic calciﬁcation have been
associated with cardiovascular disease (CVD) and chronic heart failure
(CHF), changes in pathophysiological functions are reported during
sea level altitude; however, Few study have explored altitude differ-
ence(2260m, 3300m) of change levels of serum high mobility group
box 1 protein (HMGB1), Fetuin-A in patients with congestive heart
failure and effects on ventricular remodeling. The aim of the present
study was to evaluate the effect the altitude difference explore on
HMGB1, Fetuin-A, and to study the relationship between changes of
HMGB1, Fetuin-A and left ventricular mass index (LVMI), mean wall
stress (MWS) and cardiac function.
METHODS A total of 129 consecutive patients with CHF with matched
age and sex were enrolled, and CHF patients were divided into high
altitude group (3300m) (n¼ 62) and moderate altitude group (2260m)
